Future Challenges in Pharmacy Benefits Management

This white paper discusses the rising costs associated with pharmacy benefits management (PBM) in the U.S. healthcare system and the urgent need for reform to enhance affordability and health outcomes for patients. It outlines how prescription drug spending has tripled over the last 25 years, driven by the influence of legacy PBMs that prioritize profits over patient care. The paper details the monopolistic practices of these PBMs and their detrimental effects on independent pharmacies, which are increasingly closing due to unsustainable reimbursement rates. The document emphasizes the importance of pharmacists in the healthcare system and advocates for federal reforms that would dismantle these monopolistic practices. It also highlights the growing dissatisfaction among plan sponsors with PBM services, citing a decline in satisfaction due to limited transparency and poor cost management. The paper calls for decisive action to ensure that pharmacy care is accessible and affordable for all Americans, particularly in underserved communities.